Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.450
-0.050 (-3.33%)
May 15, 2025, 10:01 AM - Market open
Metagenomi Revenue
Metagenomi had revenue of $4.13M in the quarter ending March 31, 2025, a decrease of -63.02%. This brings the company's revenue in the last twelve months to $45.26M, down -4.22% year-over-year. In the year 2024, Metagenomi had annual revenue of $52.30M with 16.84% growth.
Revenue (ttm)
$45.26M
Revenue Growth
-4.22%
P/S Ratio
1.23
Revenue / Employee
$224,074
Employees
202
Market Cap
54.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 52.30M | 7.54M | 16.84% |
Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
Dec 31, 2021 | 243.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 1 day ago - Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 - GlobeNewsWire
- 1 day ago - Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewsWire
- 13 days ago - Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewsWire
- 2 months ago - Metagenomi Reports Business Updates and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems - GlobeNewsWire
- 3 months ago - Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 4 months ago - Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewsWire
- 4 months ago - Metagenomi Announces New Appointment to its Board of Directors - GlobeNewsWire